Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 410

    AstraZeneca, Chi-Med take kidney cancer drug into final testing

    AstraZeneca, Chi-Med take kidney cancer drug into final testing

    Ruby Khatun Khatun30 Jun 2017 11:45 AM IST
    AstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib...
    Sales hopes for new Novartis, Merck heart drugs under microscope

    Sales hopes for new Novartis, Merck heart drugs under microscope

    Ruby Khatun Khatun30 Jun 2017 9:42 AM IST
    London: Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as...
    Philips buys US cardiac-implant firm for 1.9 billion euros

    Philips buys US cardiac-implant firm for 1.9 billion euros

    Ruby Khatun Khatun29 Jun 2017 4:02 PM IST
    The Hague: Dutch electronics giant Philips announced it was buying for 1.9 billion euros ($2.2 billion) a specialist US company manufacturing...
    USFDA gives nod to Zydus Cadila

    USFDA gives nod to Zydus Cadila's overactive bladder tablets

    Ruby Khatun Khatun29 Jun 2017 4:00 PM IST
    New Delhi: The US Food and Drug Administration (USFDA) has given final approval to drug firm Zydus Cadila to market oxybutynin chloride tablets used...
    Unichem Laboratories to focus on expansion of product portfolio

    Unichem Laboratories to focus on expansion of product portfolio

    Ruby Khatun Khatun29 Jun 2017 3:58 PM IST
    Mumbai: Unichem Laboratories said it will continue to focus on expansion of the product portfolio and increasing market penetration in both domestic...
    Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases

    Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases

    Ruby Khatun Khatun29 Jun 2017 9:58 AM IST
    Holzkirchen: Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the European Commission (EC) has approved...
    AstraZeneca cancer drug trial prompts investors to take options cover

    AstraZeneca cancer drug trial prompts investors to take options cover

    Ruby Khatun Khatun29 Jun 2017 9:58 AM IST
    London/New York: Investors in drugmaker AstraZeneca have taken defensive positions in the options market ahead of eagerly awaited results of a major...
    Natco Pharma receives final approval for generic Azacitidine for injection for USA market

    Natco Pharma receives final approval for generic Azacitidine for injection for USA market

    Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
    Hyderabad: Natco Pharma Limited announced that it has got the final approval of Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug...
    Zydus Cadila gets final approval from USFDA for Hepatitis B tablets

    Zydus Cadila gets final approval from USFDA for Hepatitis B tablets

    Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
    AHMEDABAD: Cadila Healthcare Ltd (Zydus Cadila) said here on Tuesday that it has received the final approval from the USFDA to market Entecavir...
    Glenmark gets USFDA nod for generic anti-inflammatory drug

    Glenmark gets USFDA nod for generic anti-inflammatory drug

    Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for its generic version of anti-inflammatory drug...
    Merck heart drug surprises with positive result; questions linger

    Merck heart drug surprises with positive result; questions linger

    Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
    Merck & Co said on Tuesday its experimental cholesterol drug from a class with a history of consistent failure lowered deaths and heart attacks in...
    Health Startup Dozee CEO Mudit Dandwate forearm ripped off by crocodile

    Health Startup Dozee CEO Mudit Dandwate forearm ripped off by crocodile

    Ruby Khatun Khatun27 Jun 2017 4:07 PM IST
    Bengaluru: A bid to save his dogs that had strayed into a lake in neighbouring Ramanagar district cost a city-based entrepreneur looses his arm, as a...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok